GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InfuSystems Holdings Inc (AMEX:INFU) » Definitions » Beneish M-Score
中文

InfuSystems Holdings (InfuSystems Holdings) Beneish M-Score : -2.72 (As of Apr. 24, 2024)


View and export this data going back to 1992. Start your Free Trial

What is InfuSystems Holdings Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.72 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for InfuSystems Holdings's Beneish M-Score or its related term are showing as below:

INFU' s Beneish M-Score Range Over the Past 10 Years
Min: -4.43   Med: -3.02   Max: -2.38
Current: -2.72

During the past 13 years, the highest Beneish M-Score of InfuSystems Holdings was -2.38. The lowest was -4.43. And the median was -3.02.


InfuSystems Holdings Beneish M-Score Historical Data

The historical data trend for InfuSystems Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InfuSystems Holdings Beneish M-Score Chart

InfuSystems Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.14 -2.38 -3.11 -3.21 -2.72

InfuSystems Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.21 -2.95 -2.71 -2.68 -2.72

Competitive Comparison of InfuSystems Holdings's Beneish M-Score

For the Medical Instruments & Supplies subindustry, InfuSystems Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InfuSystems Holdings's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where InfuSystems Holdings's Beneish M-Score falls into.



InfuSystems Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of InfuSystems Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0271+0.528 * 1.0982+0.404 * 0.9562+0.892 * 1.1444+0.115 * 1.0176
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8989+4.679 * -0.099927-0.327 * 0.9512
=-2.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $19.8 Mil.
Revenue was 31.771 + 31.909 + 31.735 + 30.37 = $125.8 Mil.
Gross Profit was 14.881 + 16.246 + 16.442 + 15.54 = $63.1 Mil.
Total Current Assets was $30.6 Mil.
Total Assets was $102.9 Mil.
Property, Plant and Equipment(Net PPE) was $46.0 Mil.
Depreciation, Depletion and Amortization(DDA) was $12.5 Mil.
Selling, General, & Admin. Expense(SGA) was $58.0 Mil.
Total Current Liabilities was $15.7 Mil.
Long-Term Debt & Capital Lease Obligation was $34.9 Mil.
Net Income was 0.072 + 0.689 + 0.435 + -0.324 = $0.9 Mil.
Non Operating Income was -0.02 + -0.014 + 0.002 + -0.035 = $-0.1 Mil.
Cash Flow from Operations was 4.658 + 4.264 + 2.452 + -0.151 = $11.2 Mil.
Total Receivables was $16.9 Mil.
Revenue was 28.83 + 27.279 + 27.042 + 26.763 = $109.9 Mil.
Gross Profit was 14.073 + 16.219 + 14.901 + 15.367 = $60.6 Mil.
Total Current Assets was $24.8 Mil.
Total Assets was $99.4 Mil.
Property, Plant and Equipment(Net PPE) was $48.0 Mil.
Depreciation, Depletion and Amortization(DDA) was $13.4 Mil.
Selling, General, & Admin. Expense(SGA) was $56.4 Mil.
Total Current Liabilities was $14.5 Mil.
Long-Term Debt & Capital Lease Obligation was $36.9 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(19.83 / 125.785) / (16.871 / 109.914)
=0.15765 / 0.153493
=1.0271

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(60.56 / 109.914) / (63.109 / 125.785)
=0.550976 / 0.501721
=1.0982

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (30.62 + 45.952) / 102.915) / (1 - (24.779 + 48.003) / 99.388)
=0.255969 / 0.267698
=0.9562

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=125.785 / 109.914
=1.1444

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(13.36 / (13.36 + 48.003)) / (12.508 / (12.508 + 45.952))
=0.217721 / 0.213958
=1.0176

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(58.031 / 125.785) / (56.412 / 109.914)
=0.461351 / 0.513238
=0.8989

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((34.9 + 15.713) / 102.915) / ((36.918 + 14.467) / 99.388)
=0.491794 / 0.517014
=0.9512

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(0.872 - -0.067 - 11.223) / 102.915
=-0.099927

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

InfuSystems Holdings has a M-score of -2.72 suggests that the company is unlikely to be a manipulator.


InfuSystems Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of InfuSystems Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


InfuSystems Holdings (InfuSystems Holdings) Business Description

Traded in Other Exchanges
Address
3851 West Hamlin Road, Rochester Hills, MI, USA, 48309
InfuSystems Holdings Inc is a United States based healthcare service provider. It offers Infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care from the locations in the United States and Canada. The company provides products and services to hospitals, oncology practices and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The segments of the company are Integrated Therapy Services (ITS) and Durable Medical Equipment (DME) services, of which key revenue is derived from the ITS segment.
Executives
Jerod Funke officer: EVP-Chief HR Officer 3851 WEST HAMLIN RD, ROCHESTER HILLS MI 48309
R. Rimmy Malhotra director C/O COMMAND CENTER, INC., 3609 S WADSWORTH BLVD., SUITE 250, LAKEWOOD CO 80235
Gregg Owen Lehman director 309 HADDON COURT, FRANKLIN X1 37067
Richard Dilorio officer: Executive Vice President 31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Barry G Steele officer: Executive VP and CFO 500 TOWN CENTER DR., SUITE 200, DEARBORN MI 48126
Carrie Lachance officer: Executive VP and COO 31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Christopher R. Sansone director C/O SANSONE ADVISORS, LLC, 151 BODMAN PLACE, SUITE 100, RED BANK NJ 07701
Addam Chupa officer: Executive VP and CIO 3851 WEST HAMLIN ROAD, ROCHESTER HILLS MI 48309
Kevin Whitman officer: VP and Corporate Controller 31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Thomas Mark Ruiz officer: VP of Sales and Marketing 31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Boyd Ralph F Jr director
Paul Andrew Gendron director 740 BANDIT TRAIL, KELLER TX 76248
Jeannine Sheehan officer: Chief Administrative Officer 31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Blueline Capital Partners Ii, L.p. director 3480 BUSKIRK AVENUE, SUITE 214, PLEASANT HILL CA 94523
Meridian Tsv Ii, Lp 10 percent owner 405 WEED STREET, NEW CANAAN CT 06840